Alnylam Pharmaceuticals
ALNY
#443
Rank
โ‚ฌ45.09 B
Marketcap
341,33ย โ‚ฌ
Share price
1.06%
Change (1 day)
48.11%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company